 |
|
Challenges of HIV-1 subtype diversity
May 22, 2008Genetic variation of HIV-1 explored
A review article in the New England Journal of Medicine explores the genetic variation of HIV-1 and its implications for preventing and treating the disease. Francine McCutchan, Ph.D., a researcher with the U.S. Military HIV Research Program, co-authored the article, which appeared in the April 10, 2008 edition.
HIV-1 is classified into several subtypes, or clades, which are denoted by letters. Subtype B is most prevalent in the Americas, whereas clades A, C and D are most prevalent in Sub-Saharan Africa, the region that remains most severely affected by the pandemic.
Advances in full-genome sequencing, along with expanded disease surveillance, have enabled researchers to identify circulating and recombinant forms of the disease as well.
"Given the diversity of HIV-1, gathering and classifying its strains has been very challenging. Nevertheless, this data provides the foundation for understanding the virus, its spread and how to combat it," said Dr. McCutchan.
The authors address the implications viral diversity has on HIV prevention, vaccine development and antiretroviral therapy. For example, subtypes and their interaction with the human host may influence disease progression and transmission. They cite a cohort study in the Rakai district in Uganda, which suggested that HIV-1 disease progression is more rapid, and the risk of death is greater, among persons infected with subtype D (with recombinant forms or multiple subtypes) than those infected with subtype A.
Henry M. Jackson Foundation for the Advancement of Military Medicine
Advances in full-genome sequencing, along with expanded disease surveillance, have enabled researchers to identify circulating and recombinant forms of the disease as well.
"Given the diversity of HIV-1, gathering and classifying its strains has been very challenging. Nevertheless, this data provides the foundation for understanding the virus, its spread and how to combat it," said Dr. McCutchan.
The authors address the implications viral diversity has on HIV prevention, vaccine development and antiretroviral therapy. For example, subtypes and their interaction with the human host may influence disease progression and transmission. They cite a cohort study in the Rakai district in Uganda, which suggested that HIV-1 disease progression is more rapid, and the risk of death is greater, among persons infected with subtype D (with recombinant forms or multiple subtypes) than those infected with subtype A.
Henry M. Jackson Foundation for the Advancement of Military Medicine
Hiv-1 Current Events and Hiv-1 News RSSHoping for a fluorescent basket case
Although recent advances have raised hopes that a protective vaccine can be developed, acquired immunodeficiency syndrome (AIDS) remains a major public health problem.
Maternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding.
Scientists join forces to explain HIV spread in Central and East Africa
Scientists studying biology and geography may seem worlds apart, but together they have answered a question that has defied explanation about the spread of the HIV-1 epidemic in Africa.
Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids.
Link uncovered between viral RNA and human immune response
In its fight against an intruding virus, an enzyme in our immune system may sense certain types of viral RNA pairs, according to scientists.
In vitro antibody production enables HIV infection detection in window period -- key to safer blood
Researchers in Israel and Kenya have shown that the contribution of variable degrees of immune suppression, either due to existing chronic infections such as parasitemias and/or nutrition, in different populations may influence and prolong the serological-diagnostic window period of HIV.
AIDS discovered in wild chimpanzees
Although the AIDS virus (HIV-1) entered the human population through chimpanzees, scientists have long believed that chimpanzees don't develop AIDS.
Penn-Wistar team gains insight into HIV vaccine failure
A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines.
Genetic Variation Associated With Survival Advantage in African Americans With HIV
From the start of the HIV epidemic, it appeared that some of the people who were infected with the virus were able to ward off the fatal effects of the disease longer than others.
Study offers insights into failed HIV-1 vaccine trial
Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring the virus - centered on the hypothesis that high levels of baseline Ad5-specific neutralizing antibodies may have increased HIV-1 acquisition among the study subjects who received the vaccine by increasing Ad5-specific CD4+ T-cells that were susceptible to HIV-1 infection.
More Hiv-1 Current Events and Hiv-1 News Articles
 |
HIV Protocols: Second Edition (Methods in Molecular Biology) by Vinayaka R. Prasad (Editor), Ganjam V. Kalpana (Editor) Despite major advances in HIV treatment, many areas require more study, in order to create efficacious, potent antiretrovirals that can suppress viral load completely and durably without toxic side effects, to define unknown drug targets and fine-tune known targets, and to better understand the interplay between viral and host factors. In "HIV Protocols, Second Edition", expert researchers provide clear, state-of-the-art methods for the study of HIV. Directed toward three specific goals, this text aims to document up-to-date protocols for select aspects of HIV biology, to bring together both virological and immunological approaches in a single, convenient volume, and to present a comprehensive account of a range of techniques not available in any existing HIV protocol book. As a volume... |
 |
Biro Directed By: Ntare Guma Mbaho Mwine |
 |
How to Lose a Guy in 10 Days: Day 1 - Sorry Baby, I Got the Hiv Bear Party (Primary Contributor) |
 |
Home Access HIV - 1 Express Test System - 1 ea by Home Access Next Day Results* Contains one single-use sample collection kit |
|
Neutral Disinfectant Cleaner, Kills Over 120 Viruses, Including Hepatitis, Hiv, Flu, German Measles, Herpes Simplex and Many More. Cleans and Disinfects!. 1 Galllon Concentrate Makes 65 Gallons of Ready to Use Product by Misco This Gallon Cleaner is very Concentrated. 1 Gallon Makes 65 Gallons Of Ready To Use Product. This disinfectant is Great for our whole house! Use it i n your Kitchen, Bathroom tile floors, Stainless Steel and much more. It Kills Over 120 Viruses. | |
 |
Angels in America Starring: Al Pacino, Meryl Streep, Emma Thompson, Patrick Wilson, Mary-Louise Parker Directed By: Mike Nichols Academy Award-winners Al Pacino, Meryl Streep and Emma Thompson lead an all-star cast in a 6-hour HBO Films Event. Directed by Mike Nichols and written by Tony Kushner based on his Pulitzer Prize-winning play: Angels in America. |
 |
Lutron S600H-IV Electronics Skylark Dimmer, Ivory by Lutron Ivory, Single Pole Slide Dimmer, Skylark Designer Style, Slide To Off, Full Range Dimming, 600W Capacity, Wallplate Not Included, UL Listed, CSA Certified, Clam Shell Package. |
 |
1.02ct Cushion Cut Center HI-VS2 EGL Certificate This 1.02 carat Cushion cut diamond is set on a 14kt white gold ring with 0.20 carats of round diamonds. With a total carat weight of 1.22 |
|
HIV-1 MedMira Ab Test (50 per box) by MedMira | |
 |
Gundam Mg Rx-93-V2 Hi-V Gundam 1/100 Scale Model Kit by Bandai Originally appearing in the "Beltorchika's Children" novel, the Hi-Nu Gundam finally makes its plastic kit debut in Bandai's popular Master Grade series. Considered one of the most powerful mobile suits in the Universal Century timeline, Hi-Nu Gundam is a completed version of the prototype Nu Gundam that appeared in "Mobile Suit Gundam: Char's Counterattack," and comes armed with a beam rifle, beam sabers, shield, and an enhanced Nu hyper bazooka for some truly devastating offensive attacks. It also features a revised fin funnel system that extend from the back like a pair of angelic wings; each fin funnel is detachable and can be displayed with the included effect parts as though it's flying towards its target and ready to fire! As usual with Master Grade kits, its inner body frame comes... |
| © 2009 BrightSurf.com |